ArticleBlood advances2021

Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphoma.

Sattva S Neelapu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.